Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Call for discussion of un-audited financial results for the quarter and half-year ended September 30, 202027-10-2020
27-10-2020
Strides Pharma Science Ltd - 532531 - Certificate Pursuant To Regulation 40 (9) Of SEBI (LODR) Regulations, 2015.
Pursuant to Regulation 40 (9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Compliance Certificate for the half year ended on September 30, 2020 duly certified by the Practicing Company Secretary. Request you to kindly take the same on record.27-10-2020
Strides Pharma Science Ltd - 532531 - Compliance Certificate - For The Half - Year Ended 30.09.2020
As per the requirement of Regulation 7(3) of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015, we hereby confirm that the activities in relation to share transfer facility for the period from April 1, 2020 to September 30, 2020 are maintained with the Company's Registrar and Share Transfer Agent, M/s. KFin Technologies Private Limited (Formerly, Karvy Fintech Private Limited), Hyderabad who are registered with SEBI vide registration number INR000000221. Accordingly, the compliance in respect of Regulation 7(2) is ensured.27-10-2020
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
This has reference to our letter dated October 23, 2020 relating to intimation of Board Meeting scheduled to be held on Thursday, October 29, 2020 to consider and approve the Unaudited Financial Results (Standalone and Consolidated basis) for the quarter and half year ended September 30, 2020. In compliance with Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, please find enclosed copies of newspaper advertisements published in Business Standard (English Edition) and Lokmat (Marathi Edition), both dated October 23, 2020. This is for your information and records.23-10-2020
Strides Pharma Science Ltd - 532531 - Board Meeting Intimation for Announcement Of Board Meeting Under Regulation 29 (1) Of SEBI Listing Regulations
Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2020 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday, October 29, 2020 to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2020. Further, as per the provisions of the Company's Code for Prohibition of Insider Trading, trading window for designated persons of the Company is closed from Thursday, October 1, 2020 to Saturday, October 31, 2020 (both days inclusive). This is for your kind information and record purposes.23-10-2020
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pronomz Ventures LLP22-10-2020
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Karuna Business Solution LLP22-10-2020
Strides Pharma Science Ltd - 532531 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0463214 Name of the Signatory :- Manjula RamamurthyDesignation :- Company Secretary and Compliance Officer21-10-2020
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 20, 2020 for Abusha Investment & Management Services LLP20-10-2020
Strides Pharma Science Ltd - 532531 - Shareholding for the Period Ended September 30, 2020
Strides Pharma Science Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here20-10-2020